ArticleThe oncologist2023

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.

Gregory E Sanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.